Repros Therapeutics Inc  

(Public, NASDAQ:RPRX)   Watch this stock  
Find more results for RPRX
15.98
+0.28 (1.78%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.36 - 16.23
52 week 13.93 - 29.79
Open 15.60
Vol / Avg. 175,468.00/334,321.00
Mkt cap 367.99M
P/E     -
Div/yield     -
EPS -1.36
Shares 23.03M
Beta 0.00
Inst. own 113%
May 5, 2014
Q1 2014 Repros Therapeutics, Inc. Earnings Release (Estimated) Add to calendar
Mar 18, 2014
Repros Therapeutics, Inc. at Bank of America Merrill Lynch Smid Cap Conference
Mar 13, 2014
Q4 2013 Repros Therapeutics, Inc. Earnings Release
Feb 10, 2014
Repros Therapeutics, Inc. at Biotechnology Industry Organization CEO & Investor Conference
Feb 6, 2014
Repros Therapeutics, Inc. Conference Call With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -34.97% -52.40%
Return on average equity -36.48% -56.31%
Employees 25 -
CDP Score - -

Address

SUITE B-7, 2408 Timberloch Place
THE WOODLANDS, TX 77380
United States - Map
+1-281-7193400 (Phone)
+1-281-7193446 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.

Officers and directors

Nola E. Masterson Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Joseph S. Podolski President, Chief Executive Officer, Director
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Katherine A. Anderson CPA Chief Financial Officer, Chief Accounting Officer, Secretary
Age: 55
Bio & Compensation  - Reuters
Jaye L. Thompson Ph.D. Senior Vice President - Clinical and Regulatory
Age: 47
Bio & Compensation  - Reuters
Ronald D. Wiehle Ph.D. Vice President - Research & Development
Age: 64
Bio & Compensation  - Reuters
Joachim F. Wernicke Chief Medical Officer
Age: 65
Bio & Compensation  - Reuters
Michael Suesserman Director
Bio & Compensation  - Reuters
Daniel F. Cain Independent Director
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Saira Ramasastry Independent Director
Age: 38
Bio & Compensation  - Reuters
Michael G. Wyllie Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters